2021-01-04,b'$ZIOP selling half of my position here at 2.87 2.88 :) holding the rest for over $3'
2021-01-04,b'RT @pharmamaven: Added $ZIOP Fri IRA rollover. Postma should take his rightful board spot &amp; chairman appt brings large open mkt buys. Sever\xe2\x80\xa6'
2021-01-04,b'RT @AnExpertOne1: @Biotech2050 On the way; may take more FIRE = \n\n1) R&amp;D Day w/ Dr. Rosenberg 1st QTR \n\n2) Treat some NEO TCR patients\n\n3)\xe2\x80\xa6'
2021-01-04,b'RT @pharmamaven: Added $ZIOP Fri IRA rollover. Postma should take his rightful board spot &amp; chairman appt brings large open mkt buys. Sever\xe2\x80\xa6'
2021-01-04,"b'Stocks with greater movement, last 15 minutes\n\n$ZIOP +/- 1.26% ZIOPHARM Oncology Inc\n$CRSP +/- 1.03% CRISPR Therapeutics AG\n$AMRS +/- 0.91% Amyris Inc.\n$SUM +/- 0.83% Summit Materials Inc. Class A\n$CCJ +/- 0.7% Cameco Corporation\nhttps://t.co/erhNulczWb'"
2021-01-04,"b'@pharmamaven Can\'t wait to hear more from Dr. Rosenberg 1st QTR, on this topic, *Last Man Standing* @ NCI as to non-viral Gene Therapy Sleeping Beauty Transposon/ase NeoAntigen TCR (no more ""VIRAL"" NEO TCR or ""TIL"" trials).....freeing up more patients&gt;\n\nhttps://t.co/LaEvMvebN5\n\n$ZIOP'"
2021-01-04,b'Added $ZIOP Fri IRA rollover. Postma should take his rightful board spot &amp; chairman appt brings large open mkt buys. Several CAR patients dosed in Asia 1 day RPM non-viral w/ advantages over Viral/TIL with trial starting. TCR trials coming &amp; R&amp;D day this Qtr w/ DrRosenberg/June.'
2021-01-04,"b'Not sure, but maybe the same for Korea or even Taiwan? (maybe not so for China) - sounds like one huge competitive advantage for $ZIOP &amp; possibly $PSTX too (non-viral) - capture that Japan &amp; other Asian market - @ziopharm via Eden BioCell already entrenched over there, .....huge!'"
2021-01-04,"b'$ZIOP \n\nAnother thing I learned this weekend, watching some Video Presentation that mentioned a non-viral CarT trial in Japan - very interesting tidbit - did you know that in Japan, you cannot treat patients in a Clinical Trial there, with a Lentivirus or Retrograde Virus vector.'"
2021-01-04,"b'$ZIOP\n\nAnd, should not be an issue now, with patients previously in line first for ""Viral"" NEO TCR trial or ""TIL"" trial patients placed in, w/ recent talk of ""needing to build up the patient pool"" @ NCI (Bethesda) - could end up dosing more quickly (to include Vaccine now avail).'"
2021-01-04,"b'$ZIOP $GILD\n\nHere it is - NCI Dr. Rosenberg\'s website, showing that SB NeoAntigen TCR trial is Active &amp; Updated recently last Thursday and ""TIL"" &amp; ""Viral"" NeoAntigen TCR trials are Suspended with all contacts information gone, &amp; most likely no more.....&gt;\n\nhttps://t.co/LaEvMvebN5'"
2021-01-04,b'Take a look at this Watchlist: \n$ATIF $FSM $SNSS $ZIOP\n\n #scnDollHiVol   \n\nDateTime: 2021-01-04 13:07 ET'
2021-01-04,"b'Also, for $GILD I think you need a much better ""non-viral"" solution than MaxCyte for CAR/TCR, mRNA type that has transient effect &amp; required multiple dosing, probably not so sustaining/persistent &amp; w/ Sleeping Beauty Trans. they were able to re-dose at MD Anderson early on\n$ZIOP'"
2021-01-04,"b'$ZIOP So, from what I have posted, no surprise that ""TIL"" trial &amp; ""Viral"" NeoAntigen TCR trial is no longer Active @ NCI/NIH - IMO, the latter a mutual decision by $GILD &amp; Dr. Rosenberg/NCI due to cost factor or speed, &amp; I don\'t think they could scale it for ""multiple"" Neo.'"
2021-01-04,"b'$ZIOP $GILD #KITE \n\nWhat SAR said about ""TIL"" &gt;\n\n""TCR T-cell therapy utilizes peripheral lymphocytes, this represents an advantage over TIL therapy, he said....""\n\nRead more here&gt;\n\nhttps://t.co/7qfu3m8IZ8'"
2021-01-04,"b'...have been ramping up their own NeoAntigen TCR platform down the road at Gaithersburg, Maryland (many Job apps) &amp; may not have even needed NCI/NIH help anymore(?) - they still see huge potential &amp; that CRADA has been ongoing for 4+ years now...&amp; this year very slow\n\n$ZIOP $GILD'"
2021-01-04,"b'$ZIOP \n\nTHREAD:\n\nSo, we have known for some time now, Dr. Rosenberg\'s view on ""TIL"" &amp; high cost of ""Virus"" vector for trials (&amp; heard latter from Dr. Cooper laughing on ""how few patients SAR has treated"" several years ago) &amp; from what I have mentioned, KITE/Gilead ......&gt;\n\n$GILD'"
2021-01-04,b'RT @Biotech2050: $ZIOP $PGEN $ATNM $KPTI $CRMD $SGMO\n@SangamoTx @Precigen @Karyopharm @ActiniumPharma @ziopharm  \n\nAdd on your undervalued\xe2\x80\xa6'
2021-01-04,b'RT @Biotech2050: $ZIOP $PGEN $ATNM $KPTI $CRMD $SGMO\n@SangamoTx @Precigen @Karyopharm @ActiniumPharma @ziopharm  \n\nAdd on your undervalued\xe2\x80\xa6'
2021-01-04,b'RT @Biotech2050: $ZIOP $PGEN $ATNM $KPTI $CRMD $SGMO\n@SangamoTx @Precigen @Karyopharm @ActiniumPharma @ziopharm  \n\nAdd on your undervalued\xe2\x80\xa6'
2021-01-04,b'@Biotech2050 On the way; may take more FIRE = \n\n1) R&amp;D Day w/ Dr. Rosenberg 1st QTR \n\n2) Treat some NEO TCR patients\n\n3) Submit new TCR-T IND by $ZIOP\n\n4) News on several CU RPM CD19 CarT patients -data update\n\n5) Patients treated @ MDA RPM CD19 CarT\n\n6) Postma on Board\n\n7) TCR-T doses summer'
2021-01-04,b'Rose Above 50 DMA today: $ZIOP ... https://t.co/qwiJH6vr1O'
2021-01-04,b'Ask not why $ZIOP is up $0.14 and now touched $2.66 ($570M market cap)\n\nAsk why is $ZIOP sub $1.5B (~$7.50 per share)\n\n200% upside needed to reach fair values per Jefferies https://t.co/rguqdu2zYs'
2021-01-04,b'I LOVE YOU $ZIOP \xe2\x9d\xa4\xef\xb8\x8f\xf0\x9f\x9a\x80\xe2\x9d\xa4\xef\xb8\x8f'
2021-01-04,"b'RT @AnExpertOne1: Also, $ZIOP huge potential in HEME (blood tumors) with pretty much the same CarT construct as $PGEN &amp; same kill switch &amp;\xe2\x80\xa6'"
2021-01-04,"b'RT @AnExpertOne1: $PGEN I can understand the excitement on Precigen; if what Dr. Helen has eluded to is truly occurring, with the early dat\xe2\x80\xa6'"
2021-01-04,"b'Also, $ZIOP huge potential in HEME (blood tumors) with pretty much the same CarT construct as $PGEN &amp; same kill switch &amp; same membrane bound IL15 that activates  CAR In Vivo, &amp; those RPM CD19 CarT patients have been treated with that Tx, compassionate use like CLLS once did -huge'"
2021-01-04,"b""$PGEN I can understand the excitement on Precigen; if what Dr. Helen has eluded to is truly occurring, with the early data (signs), &amp; low T cell numbers, &amp; it pans out as expected then to the moon; but, don't forget about $ZIOP - minimum single digit royalties on PGEN CarT , etc."""
2021-01-04,"b'$ZIOP \n\nShhhhh! This would have been my 2021 pick, had I loved the fanfare of BioPick contests; that said, just my Opinion, &amp; need certain things to happen, one of which, the low priced penny flippers to pack up &amp; leave!...haha.  So far so good.\n\n{Of course there is more to come}'"
2021-01-04,b'$ZIOP Enjoy the weekend everyone! Cheers! \xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd -4.91 % change recently https://t.co/NX7N2PHnnM'
2021-01-04,b'RT @AnExpertOne1: Just trying to help others get a grasp on the Scientific support for what $ZIOP &amp; $PGEN have here - what could be a grand\xe2\x80\xa6'
2021-01-04,b'RT @AnExpertOne1: Just trying to help others get a grasp on the Scientific support for what $ZIOP &amp; $PGEN have here - what could be a grand\xe2\x80\xa6'
2021-01-04,b'RT @SilvioDanailov: The most undervalued company in 2020 is $ZIOP @ziopharm https://t.co/KgLhcsR7Rm'
2021-01-04,"b""RT @biostonks: I've created an Excel spreadsheet that will self-update the market cap movement of 74 gene therapy players and will post the\xe2\x80\xa6"""
2021-01-04,"b""RT @biostonks: I've created an Excel spreadsheet that will self-update the market cap movement of 74 gene therapy players and will post the\xe2\x80\xa6"""
2021-01-04,"b""RT @biostonks: I've created an Excel spreadsheet that will self-update the market cap movement of 74 gene therapy players and will post the\xe2\x80\xa6"""
2021-01-04,b'RT @Biotech2050: $ZIOP $PGEN $ATNM $KPTI $CRMD $SGMO\n@SangamoTx @Precigen @Karyopharm @ActiniumPharma @ziopharm  \n\nAdd on your undervalued\xe2\x80\xa6'
2021-01-04,"b""RT @biostonks: I've created an Excel spreadsheet that will self-update the market cap movement of 74 gene therapy players and will post the\xe2\x80\xa6"""
2021-01-04,b'RT @Biotech2050: $ZIOP $PGEN $ATNM $KPTI $CRMD $SGMO\n@SangamoTx @Precigen @Karyopharm @ActiniumPharma @ziopharm  \n\nAdd on your undervalued\xe2\x80\xa6'
2021-01-04,b'RT @Biotech2050: $ZIOP $PGEN $ATNM $KPTI $CRMD $SGMO\n@SangamoTx @Precigen @Karyopharm @ActiniumPharma @ziopharm  \n\nAdd on your undervalued\xe2\x80\xa6'
2021-01-04,b'$ZIOP $PGEN $ATNM $KPTI $CRMD $SGMO\n@SangamoTx @Precigen @Karyopharm @ActiniumPharma @ziopharm  \n\nAdd on your undervalued pre-clinical thro\xe2\x80\x99 phase 3 company trading at sub $1.5B market cap (Value per Jeffries) via a response to this tweet.\n\nRT if you own one of the above. https://t.co/tuKITosZxx'
2021-01-03,b'Technical Analysis Alert: $ZIOP daily chart has developed a Strong Sell signal. https://t.co/YZeQYAH2g1'
2021-01-03,"b""I've created an Excel spreadsheet that will self-update the market cap movement of 74 gene therapy players and will post the changes at the end of each week in 21'. $VRTX $SRPT $EXAS $CRSP $RARE $ARWR $BBIO $RCKT $EDIT $BLUE $SGMO $QURE $RGNX $FLGT $ZIOP $VYGR $SIOX $ABEO https://t.co/I0ROS0RjAq"""
2021-01-03,b'Short sale vol (not short interest) for $DOYU on 2020-12-31 is 67%. https://t.co/fiWQOXKtF6 $ZI 55% $VBIV 69% $GEN 62% $ZIOP 61%'
2021-01-03,"b""$ZIOP I'd like to make an exit, just not now  -4.91 % change recently\n https://t.co/NX7N2PHnnM"""
2021-01-03,b'$ZIOP this is the time you buy equities thank you fed  -4.91 % change recently https://t.co/NX7N2PHnnM'
2021-01-03,"b""RT @AnExpertOne1: $ZIOP much better takeover candidate than $PGEN by far (if you can comprehend the Science) &amp; you don't have to deal with\xe2\x80\xa6"""
2021-01-03,"b'RT @AnExpertOne1: $ZIOP \n\nSeveral key points: \n\nEveryone else has been using ""Ex Vivo"" Activation &amp; Propagation protocol for CarT Tx; here\xe2\x80\xa6'"
2021-01-03,b'RT @AnExpertOne1: (2 of 2)\n\n2) R&amp;D shows a possible better way to overcome T cell exhaustion &amp; better cytokine= IL15 &amp; for T cells (&amp; not n\xe2\x80\xa6'
2021-01-03,"b'RT @AnExpertOne1: $PGEN So, if you do have certain solid tumors that are very difficult to treat....may need those Billions of T cells to p\xe2\x80\xa6'"
2021-01-03,b'$ALRT to divulge ongoing merger talks happening now in New York\nhttps://t.co/fK8PPZ6hwp\n\n$ARWR $WAFD $PKG $CASA $MCO $SRCL $BRKR $BAM $DBD $GAB $HNGR $DCT $TRON $DXCM $ZIOP'
2021-01-02,b'$ZIOP significant stock price movement  -4.91 % change recently https://t.co/orYbtqH9e1'
2021-01-02,b'RT @Biotech2050: #biopick2021 deadline is today. Come in and participate . Please RT. $SGMO $ZIOP $PGEN $TGTX $BMYRT $BMY $ACAD $IBB $XBI $\xe2\x80\xa6'
2021-01-02,"b'#biopick2021 deadline is today. Come in and participate . Please RT. $SGMO $ZIOP $PGEN $TGTX $BMYRT $BMY $ACAD $IBB $XBI $KPTI $CRMD $ATNM $XLRN ...., $.... https://t.co/YDkAei1mGp'"
2021-01-02,b'$ZIOP significant stock price movement  -4.91 % change recently https://t.co/NX7N2PHnnM'
2021-01-01,"b'&gt;It cites how the mbIL15 is the ""3rd signal"" to the structure and the CAR provides the other ""two signals"" &lt;\n\n&amp;\n\n""mbIL15 may provide a desired signaling enabling infused T cells to prolong persistence, thereby providing durable immune surveillance &amp; therapeutic potential.""\n\n$ZIOP'"
2021-01-01,"b'Just trying to help others get a grasp on the Scientific support for what $ZIOP &amp; $PGEN have here - what could be a grand future for both...\n\nRefresh on this ""Tethered IL15"" Paper for more - try &amp; figure out the ""3 signals"" \n\nL. Hurton &amp; LJ Cooper @ ZIOP\n\nhttps://t.co/mShFL151mH'"
2021-01-01,"b'$PGEN So, if you do have certain solid tumors that are very difficult to treat....may need those Billions of T cells to penetrate the large tumors (as SAR says @ NCI) / Epithelial tumors, etc...so you move on down the line to NeoAntigen TCR / TCR-T via $ZIOP &amp; others, other Tx.'"
2021-01-01,"b'So, not just ""In Vivo"" advantage for Activation, likely stronger T cells &amp; more effective/persistent (even small #\'s.)&gt;\n\n""IL-15, unlike IL-2, preferentially expands CD8+ T cell memory &amp; NK cells in the presence of Treg cells while promoting resistance to Treg suppression""\n\n$ZIOP'"
2021-01-01,"b'""While IL-2 has been widely used to expand T cells ex vivo in preparation for infusion into patients, preclinical work reveals that other members of the \xce\xb3c cytokine family should be considered for clinical use.""\n\n{Same reference}\n\n$ZIOP'"
2021-01-01,"b'""Current protocols traditionally expand T lymphocytes isolated from patient tumors or from peripheral blood to large magnitudes in the presence of high dose IL-2 prior to infusion."" \n\n{I know I read that IL15 is better than IL2, especially mbIL15}\n\nhttps://t.co/A6AkvS0Rrp\n\n$ZIOP'"
2021-01-01,"b'(2 of 2)\n\n2) R&amp;D shows a possible better way to overcome T cell exhaustion &amp; better cytokine= IL15 &amp; for T cells (&amp; not need as many maybe) if you have the Activation step inside the body v. outside - - - remember the ""3 signals"" needed from the ""Tethered IL15"" paper\n\n$ZIOP $PGEN'"
2021-01-01,"b'$ZIOP \n\nSeveral key points: \n\nEveryone else has been using ""Ex Vivo"" Activation &amp; Propagation protocol for CarT Tx; here comes $PGEN &amp; $ZIOP\n\n1) Ex Vivo -After LD Chemo regimen (/Leukapheresis) T cells had been engineered &amp; heavily stimulated w/ IL2 &amp;/or other cytokines\n\n(1 of 2)'"
2021-01-01,b'RT @Biotech2050: Indeed. Doubled down $ZIOP sub $3 on the news of overnight manufacturing using MBIL15 with no serious adverse events. Had\xe2\x80\xa6'
2021-01-01,b'RT @Biotech2050: Which company updates are you waiting most from #JPM21 ?\nA. $SGMO $PGEN $ZIOP\nB. $KPTI $TGTX $ACAD \n\nIf other companies in\xe2\x80\xa6'
2021-01-01,"b'@Biotech2050 They should- both 2 day admin RPM CarT Tx are nearly the same just different antigens and target indications- CD19 Heme (blood) cancer tx should be easier since what propelled KITE/JUNO to success &amp; if just as efficacious, the sky is the limit - and of course NeoAntigen TCR $ZIOP'"
2021-01-01,b'$ZIOP  new alert at https://t.co/A7qrDarJHY  #stocks #daytrading  #NYSE #NASDAQ #market 327'
2021-01-01,b'Indeed. Doubled down $ZIOP sub $3 on the news of overnight manufacturing using MBIL15 with no serious adverse events. Had doubled down $PGEN earlier this year at ~ $2.45. Hopefully both platforms work out. https://t.co/owl37FCILi'
2021-01-01,b'$ZIOP  good earnings are hopefully coming next quarter  -4.72 % change recently https://t.co/lNKjdHWEcu'
2021-01-01,b'RT @GonaloPedroNun1: Current risk in portfolio: $OPES $WIMI $ZIOP $AZN $BLPH $GILD $XOM $SHIP $WDIG $MARA $SRNE $BLCM $LKNCY $GALP $FSR $BI\xe2\x80\xa6'
2021-01-01,"b""Current risk in portfolio: $OPES $WIMI $ZIOP $AZN $BLPH $GILD $XOM $SHIP $WDIG $MARA $SRNE $BLCM $LKNCY $GALP $FSR $BIIB $HOFV $SYBX always maintain small positions (10% or less) and hedge with uncorrelated securities (risk-free secondary portfolios; LTB's and/or Corp Premium)"""
2021-01-01,"b""@llchaves Also, let's say Rosenberg can't dose someone in the Spring (but surely Vaccines improve situation), then Cooper should have New IND done in 1st QTR &amp; $ZIOP should treat TCR-T Library patients under Dr. Deniger's watch @ Houston MDA this summer; so much up ahead; &amp; R&amp;D Day 1st QTR"""
2021-01-01,"b'@llchaves So, since they did treat RPM CD19 CarT patients (of course Taiwan, but real PTs), &amp; more in 2021, the only patients not treated is by Rosenberg - &amp; rGBM trials have progressed well; maybe the new Board can get deals or acquisition by Pharma done easier; organize...my guess.\n$ZIOP'"
2021-01-01,"b'@llchaves Actually, I know what $ZIOP needs &amp; how far along they are, &amp; I also see that had this pandemic not hit, they could have easily treated some patients in NEO TCR PH2 @ NCI (entirely up to Rosenberg, not Cooper) &amp; the other RPM CD19 CarT trial, but they did tx latter patients by CU'"
2020-12-31,b'@AnExpertOne1 That\xe2\x80\x99s what $ziop needs some wins and to show advancement.  Doesn\xe2\x80\x99t help Cooper has been talking about dosing their first patient with Rosenberg for 3 years now and then nothing happens.  That\xe2\x80\x99s why they\xe2\x80\x99re in the penalty box.  Either way hope 2020 is when they bring it all home'
2020-12-31,"b'$ZIOP \n\nAnd that is it, good bye 2020 - did not seem like huge volume for such a tax loss seller panic down day - would not think it is any Top Holder dumping any or many shares....per Ameritrade volume&gt;\n\nVolume(Average)\n2,598,859\nDecember 31, 2020 4:00pm ET'"
2020-12-31,"b""I don't know - but everyone is so critical on $ZIOP but when I examine the Kitepharma website all I see is 1) tons of jobs available &amp; 2) hard to find Info on Neoantigen....last update on latter - 7/15/2019 \n\nTons of jobs in Maryland - build it up!\n\nhttps://t.co/uC9N9uXdTO\n\n$GILD"""
2020-12-31,b'$ZIOP adding more here 2.49 \xf0\x9f\xa4\x91\xf0\x9f\x94\xab'
2020-12-31,"b""$ZIOP\n\nSure will be funny - after a week or two, headlines read,\n\nRegeneron to buy Ziopharm or \n\nGilead to buy Ziopharm\n\nor \n\n$BMY to buy Ziopharm \n\nthey all could use them - don't give it away cheap man!\n\n$REGN \n\n$GILD\n\n(especially the latter - as to need)\n\nMore KITE job appls?"""
2020-12-31,"b""My #biopick2021 is $ZIOP at $12.50.  Why?  because I'm tired of this turd not delivering and am willing it to be so in 2021...hopefully a new BOD can have some impact and James Huang's work in China."""
2020-12-31,"b'$ZIOP One more:\n\nMemories Times 3 &gt;\n\nEnd of 2014 - FMR sold ""all out"" of @Ziopharm stock well under $3 to $4\n\n2015 &gt;&gt;&gt; stock flies up to $14 (3 times or so)\n\nEnd of 2018 - RJ Kirk sells ""all out"" of Ziopharm stock under $2\n\n2019 &gt;&gt;&gt; stock hits $7 in July\n\nEnd of 2020 - 52 wk lows'"
2020-12-31,"b'Insanity times TWO!\n\n1) Many Biotech names are at or close to 52 week highs so they take profits &amp; XBI crashes - dragging $ZIOP even closer to a 52 week low - AREADY CUT IN HALF THIS YEAR!....idiots!\n\n2) Tax Loss seller(s) - Benedict Arnolds that they are &gt; ""I\'m dumping!""\n\nLOL!'"
2020-12-31,b'RT @AnExpertOne1: As we know Sleeping Beauty Transposon was used in several NCI trial patients on that Ovarian Cancer trial &amp; likely others\xe2\x80\xa6'
2020-12-31,b'$ZIOP auction is now open. -3.72 % change recently https://t.co/orYbtqH9e1'
2020-12-31,"b'RT @GerryMcguire10: @Pharmdca $ziop great science (fundamentals), poor management'"
2020-12-31,b'RT @SilvioDanailov: The most undervalued company in 2020 is $ZIOP @ziopharm https://t.co/KgLhcsR7Rm'
2020-12-31,"b""This is just too funny. I guess Postma's going to get his board seat after all. $ZIOP https://t.co/qwQAieJBwL"""
2020-12-30,b'Filing for 8-K [Press/News Current Report] has been made with the SEC:  $ZIOP ZIOPHARM ONCOLOGY INC  https://t.co/OJXTWwVFWy'
2020-12-30,"b'$ZIOP New Form 8-K for ZIOPHARM Oncology, Inc.\nFrom our Stock News Alerts App'"
2020-12-30,b'$ZIOP ZIOPHARM Oncology Inc SEC Filing: Form 8-K https://t.co/z2SPrMEwnt'
2020-12-30,"b'$ZIOP #NASDAQ  8-K - ZIOPHARM ONCOLOGY INC  [B/A=0/0 - Bid/Ask Size=0/0  Volume=2,325,239  AverageVol=1,995,148  Outstanding=0] https://t.co/iku8wkEY0T'"
2020-12-30,b'$ZIOP / ZIOPHARM Oncology files form 8-K - Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing -  8-K https://t.co/9i1we4gH6L'
2020-12-30,b'Rose Above 50 DMA today: $ZIOP ... https://t.co/qwiJH6vr1O'
2020-12-30,"b'As we know Sleeping Beauty Transposon was used in several NCI trial patients on that Ovarian Cancer trial &amp; likely others.  Iovance knows that ""TIL"" therapy is not enough outside of Melanoma &amp; maybe a few other indications. \n\nNone of those chasing $ZIOP, or few are non-viral type'"
2020-12-30,"b""So, $ZIOP may end up having one of its 'worst years ever' while having an Active Phase 2 trial in NeoAntigen TCR @ NCI - while all of these BIOs are trying to copy just that (w/ Phase One's) &amp; some @ 52 wk highs&gt;\n\n$ADPT\n$IOVA - great data in TIL - but SB in it too\n$NEOG\n\n&amp; Others"""
2020-12-30,"b'$ZIOP \n\nCut in half this year, primarily due to a pitiful timed Offering prior to Springtime, &amp; the raging pandemic (hard to dose most advanced difficult trials) ....&amp; just a half dollar off of the bottom; bizarre to me that anyone would even sell one share this low, but they do.'"
2020-12-30,b'@ToddWilliamson All or nothing. Added $ZIOP recently. They can manufacture overnight CART using MBIL15 and they infused  on compassionate grounds (nearly dead patients) with early efficacy shown. Hopefully ZIOP $PGEN $SGMO will be the stars of 2021. $TGTX $KPTI $ACAD are 2021 buyout candidates'
2020-12-30,b'Which company updates are you waiting most from #JPM21 ?\nA. $SGMO $PGEN $ZIOP\nB. $KPTI $TGTX $ACAD \n\nIf other companies insert name via response to this tweet.'
2020-12-30,"b'$ZIOP \n\nRemember how much stock price popped when they signed on Dr. Rosenberg\'s right hand man from NCI last year (2019)?(D Deniger).  Or when we found out (was top secret) they also hired the patent holder on ""Tethered IL15"" ~L Hurton (?) - yep, same = mbIL15 used by Precigen!'"
2020-12-30,b'The most undervalued company in 2020 is $ZIOP @ziopharm https://t.co/KgLhcsR7Rm'
2020-12-30,"b'Just one platform (compared to $PGEN)\n\nSimilar RPM type CarT structure (w/ mbIL15 IN VIVO activation) got the market &amp; Precigen investors mega excited about the stock due to the AML data...yet, they think it can\'t work ""at all"" w/ $ZIOP CD19 RPM CarT HEME patients.\n\nBoth similar!'"
2020-12-30,"b'$ZIOP let\xe2\x80\x99s hope that 2021 gets us a full cleansing of BOD (paging chairman Postma) and establishment of clear achievable milestones and progress.  Holding on, give it time'"
2020-12-30,"b'@GerryMcguire10 @Pharmdca Agree for the most part (one of my top holdings) &amp; should roar back in 2021; some of that performing ""poorly"" was due to the 100 yr pandemic, and NCI/NIH being run by the Gov\'t, &amp; the NEO TCR trial \'dosing\' being delayed - R&amp;D Day 1st QTR w/ Dr. Rosenberg, we\'ve been told.\n\n$ZIOP'"
2020-12-30,"b'RT @GerryMcguire10: @Pharmdca $ziop great science (fundamentals), poor management'"
2020-12-30,"b'@Pharmdca $ziop great science (fundamentals), poor management'"
2020-12-30,b'$ZIOP major moves #ZIOP -4.28 % change recently https://t.co/NX7N2PHnnM'
2020-12-30,b'$ZIOP buyer at $2.96  -6.60 % change recently https://t.co/NX7N2PHnnM'
2020-12-29,b'RT @kchikian: $ZIOP added again today. Watermill will get this turned around. There is no way after that BOD fight that the large holders a\xe2\x80\xa6'
2020-12-29,b'RT @kchikian: $ZIOP added again today. Watermill will get this turned around. There is no way after that BOD fight that the large holders a\xe2\x80\xa6'
2020-12-29,"b'$ZIOP added again today. Watermill will get this turned around. There is no way after that BOD fight that the large holders are just going to sit on their hands. Likely a large rise in the share price once Watermill makes positive changes, now with 2 BOD seats likely the 3rd soon'"
2020-12-29,"b'Just want to say thanks Regeneron $REGN - maybe just for being clueless, or just not buying out $ZIOP here on the cheap, when you could or should have; I will keep buying/adding in several accounts until you or some other large Pharma figures out you should be smarter than this.'"
2020-12-29,"b'$ZIOP \n\nAdded much more @ $2.55 - some unhappy that Mr. Postma has not been seated on the Board yet, however, do they really have to have him?  Just turn 1 to 2 Independent Directors &amp; you have whole Board as you want it - then who be Chairman?\n\nThanks for low prices Degenerates!'"
2020-12-29,b'Take advantage of tax loss selling \xf0\x9f\x98\x8d got more $ZIOP 2.57 \xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80'
2020-12-29,b'RT @809trader: $ZIOP IS A BIG BUY BUY BUY HERE. Sell over $3 in January https://t.co/u0viKJ31xL'
2020-12-29,b'$ZIOP IS A BIG BUY BUY BUY HERE. Sell over $3 in January https://t.co/u0viKJ31xL'
2020-12-29,"b'$PGEN\n\nHave to admit, is holding up very well, surprisingly - you got EDIT dropping 15% here &amp; Pigeon not even flying upside down; they (shorts) must be terrified of Captain Kirk once again?  \n\n""Sure, but we can still pound @Ziopharm into the ground!"" ......lol.\n\n$ZIOP'"
2020-12-29,"b'@DanielAdams1228 Then you should also look at $ZIOP - the most advanced non-viral (sleeping beauty transposon/ase) T cell company out there, to include Phase 2 NeoAntigen TCR trial w/ Dr. Rosenberg @ NCI (dosing held up by pandemic) &amp; RPM CD19 (w/ mbIL15 IN Vivo activation) CarT, US &amp; Asia.\n$PSTX'"
2020-12-29,b'Short sale vol (not short interest) for $CLSN on 2020-12-28 is 55%. https://t.co/2NDu0B47mj $XLV 74% $SPPI 59% $ZIOP 55%'
2020-12-29,"b""$ZIOP That's rough. . .   -4.17 % change recently https://t.co/orYbtqH9e1"""
2020-12-29,b'$ZIOP  new alert at https://t.co/A7qrDarJHY  #stocks #daytrading  #NYSE #NASDAQ #market 493'
2020-12-29,b'$ZIOP  new alert at https://t.co/A7qrDarJHY  #stocks #daytrading  #NYSE #NASDAQ #market 492'
2020-12-28,b'Top losers 12/28\n$AMWL\n$IH\n$OVID\n$AY\n$CVLB\n$QDEL\n$DVAX\n$SRACU\n$WKHS\n$COE\n$TC\n$DS\n$AMRK\n$DARE\n$SBOW\n$OSUR\n$ANY\n$BEST\n$BPT\n$SYRS\n$PHAR\n$SRRK\n$NBEV\n$ATHX\n$NRIX\n$ASPN\n$NCNA\n$MCEP\n$TKAT\n$CAAS\n$EVOK\n$WW\n$RCUS\n$SE\n$DASH\n$VXRT\n$ISEE\n$ZIOP\n$GLYC\n$IMUX\n$MCF\n$FMTX\n$VIOT\n$PTON\n$VHI\n$GTEC\n$EQ'
2020-12-28,"b'Evening Most Tweeted Small Caps, check out Gambiste Top 10: $MWK $amc $UUUU $LEU $GEVO $RICK $KODK $ZIOP $NNDM https://t.co/k3uyuEbRpJ'"
2020-12-28,b'What????  already green on this pos \xf0\x9f\x98\xb3\xf0\x9f\xa4\x91 $Ziop https://t.co/pyxtqIc9rT'
2020-12-28,"b'Afternoon Most Tweeted Small Caps, check out Gambiste Top 10: $MWK $amc $UUUU $LEU $GEVO $RICK $KODK $GIK $ZIOP https://t.co/k3uyuEbRpJ'"
2020-12-28,b'#Stocks breaking down in the PM session\n\n$ET $ETRN $SFIX $ZIOP $FROG $BNTX $TEAM $ZM $AM $DDOG \n\n(+2 more results)  Scan updates every 5 secs.\n#trading #fintwit\nhttps://t.co/SmuJhj6UcY'
2020-12-28,"b'$ZIOP \n\nThe 2 New Board member BIOs are now up on Ziopharm home page - no one is yet listed as new Chairman - is that for when Postma comes on Board (soon?) or for an upcoming Vote? \n\nHolger Weis &amp;\nJaime Vieser\n\n{Oh, Scholar Rock = SRRK was also down 9% today - ex Board member?}'"
2020-12-28,b'Jesussss I started buying $Ziop today and I\xe2\x80\x99m already a bag holder \xf0\x9f\x98\xb1 thanks to my $PAVM I\xe2\x80\x99m not crying right now'
2020-12-28,b'$ZIOP Why do I keep adding to this crap? Someone please stop me \xf0\x9f\x99\x8b\xf0\x9f\x8f\xbd\xe2\x80\x8d\xe2\x99\x82\xef\xb8\x8f\xf0\x9f\x94\xab\xf0\x9f\x92\xa9\xf0\x9f\x92\xa9\xf0\x9f\x92\xa9\xf0\x9f\x92\xa9\xf0\x9f\x92\xa9\xf0\x9f\x92\xa9\xf0\x9f\x92\xa9\xf0\x9f\x92\xa9\xf0\x9f\x92\xa9\xf0\x9f\x92\xa9\xf0\x9f\x92\xa9\xf0\x9f\x92\xa9\xf0\x9f\x92\xa9\xf0\x9f\x92\xa9\xf0\x9f\x92\xa9'
2020-12-28,"b'Also seeing $PSTX flying up 24% here; they have had some decent BCMA CarT data news &amp; one recent clinical hold (then lifted) - pretty much all CAR T cell company (non-viral too)....\n\n$ZIOP much attractive to me, with the NEO TCR /TCR-T platforms; somehow 20% lower than PSTX here.'"
2020-12-28,"b""Precigen moving over $2 Billion, Ziopharm moving closer to $500 million; you guys are so damn retarded it's funny.\n\nThe crooked MMs on $ZIOP knew they had a tax loss seller this week &amp; running it down as much as they can, while they shoot up Precigen like a shooting star.\n\nLOL!"""
2020-12-28,"b'@AnExpertOne1 In the other hand hit $14\xe2\x80\x99s and drop drop drop...I doubt these buyers will make their money back anytime soon. This is just a trade for me since $Ziop can\xe2\x80\x99t even hold $3 when all bios in this universe are running. Not a good sign my friend. Stay warm, is gonna be a long winter.'"
2020-12-28,b'50 DMA Support today: $ZIOP ... https://t.co/aW7zteKP9U'
2020-12-28,b'#Stocks breaking down in the morning\n\n$SE $BYND $ETRN $SFIX $TEAM $ETSY $ZIOP $ISEE $ET \n\nScan updates every 5 secs.\n#daytrading #traders\nhttps://t.co/aurfUDY4kB'
2020-12-28,"b""$ZIOP much better takeover candidate than $PGEN by far (if you can comprehend the Science) &amp; you don't have to deal with RJ Kirk.....Ziopharm is not tied down to any major Pharma partner at the moment.....do your own DD!"""
2020-12-28,"b'(2 of 2)&gt;\n\n""Ziopharm will receive a low single digit, capped royalty on Precigen products in the field of point-of-care (P-O-C) CAR T-cell therapies."" \n\nhttps://t.co/3Oz7dCcPb1\n\n{Ignorant seller - Tax Loss}\n\n$ZIOP'"
2020-12-28,"b""Bare Minimum:  Let's say, all TCR fails, Dr. Rosenberg &amp; new program at MDA, $ZIOP TCR-T, &amp; then you know shorts publicly trash their rGBM platform &amp; bet against 'everything' brain cancer!, &amp; CD19 CarT is missing the secret Precigen sauce!(lol) - they still get this &gt;\n\n(1 of 2)"""
2020-12-28,b'$ZIOP Added 2K more here.'
2020-12-28,b'Added $ZIOP'
2020-12-28,"b'$ZIOP\n\nSetting up very well, similar to DEC 2018 (sold off hard last week of December too then) into 2019, where it would run up all the way to over $7 by July (from under $2) - need to deliver more, which they should, so let them shorts stuff themselves with CAKE now!....haha!'"
2020-12-28,b'$ZIOP\n\nAdded 4K shares so far in the IRA account so far - only had 3K in there....\n\n;-)'
2020-12-28,b'$ziop there was a reason Kirk sold his ziop and bought more $pgen'
2020-12-28,"b""$ZIOP \n\nYou gotta be dumb as dirt to think that $PGEN should be a $2 Billion valued company, &amp; possess some secret sauce that Ziopharm don't have, to attack AML, while ZIOP's CarT to fight CD19 HEME cancers is crap....&amp; then there is NEO TCR with NCI - Phase Two!\n\nHilarious."""
2020-12-28,"b'$ZIOP Well, there was 16K shares sitting there on the $2.90 Ask &amp; someone bought it all.  Maybe no dogfight this am, &amp; it runs up over $3 - - - wow, them wacky Crispr stocks valuations huh?\n\n$APTO makes a move on $4.50 &amp; moves back toward $5 soon?'"
2020-12-28,b'RT @Biotech2050: @TransparentLad @bluetheabbyssi1 My #genetherapy picks are $SGMO $PGEN $ZIOP.'
2020-12-27,b'RT @RumorMurmurBuzz: $INTV BOD to pitch reverse merger plan to shareholders in upcoming pending announcement \nhttps://t.co/aQqxh927Rv\n\n$WAF\xe2\x80\xa6'
2020-12-27,b'RT @RumorMurmurBuzz: $INTV BOD to pitch reverse merger plan to shareholders in upcoming pending announcement \nhttps://t.co/aQqxh927Rv\n\n$WAF\xe2\x80\xa6'
2020-12-27,b'$INTV BOD to pitch reverse merger plan to shareholders in upcoming pending announcement \nhttps://t.co/aQqxh927Rv\n\n$WAFD $PKG $CASA $MCO $SRCL $BRKR $BAM $DBD $GAB $HNGR $DCT $TRON $DXCM $ZIOP'
2020-12-27,b'RT @Biotech2050: @TransparentLad @bluetheabbyssi1 My #genetherapy picks are $SGMO $PGEN $ZIOP.'
2020-12-27,b'@TransparentLad @bluetheabbyssi1 My #genetherapy picks are $SGMO $PGEN $ZIOP.'
2021-01-08,b'RT @AnExpertOne1: $ZIOP \n\nWe also discussed NekTar Therapeutics as to IL15 agonist; nothing like what Precigen &amp; $ZIOP have with mbIL15 w/\xe2\x80\xa6'
2021-01-08,b'$ZIOP \n\nWe also discussed NekTar Therapeutics as to IL15 agonist; nothing like what Precigen &amp; $ZIOP have with mbIL15 w/ CAR - in fact I previously mentioned how they copy the IL15 part (almost) w/o the added CAR t cell benefit.\n\nNKTR-255 is designed to activate the IL-15 pathway'
2021-01-08,"b'$ZIOP (note the IL2 &amp; IL15 agonist together - a bit overkill - should not need both) - ""mbIL15 is best""  $PGEN - not easy to be best like PGEN/ZIOP !\n\nFDA sideswipes Neoleukin with clinical hold on lead immunotherapy candidate, sends shares plummeting - https://t.co/K9IFSeYHAy'"
2021-01-08,b'$ISR 1.44? OMG! adding!! MASSIVE NEWS. FDA APPROVED! $10 break easy\n\n$IONS $GBT $XON $CRSP $EDIT $NTLA $PBYI $BMRN $TSRO $CELG $BLUE $ALKS $ALNY $GILD $BIIB $AMGN $SGMO $ONCE $ENDP $PRGO $LCI $COLL $ANIP $MYL $OSUR $PODD $BIO $EW $ABT $MDT $ZIOP $KOOL $SRNE $CLLS $JNJ $MARA $RIOT https://t.co/UTe1BMuPPA'
2021-01-08,b'$ZIOP \n\n105K share bidder @ $3.10\n\nMarch it down bozos!....lol.'
2021-01-08,b'RT @AnExpertOne1: $ZIOP \n\nWould be nice to see at least a move up to $3.50 here (of course should be much higher); for traders (&amp; price fli\xe2\x80\xa6'
2021-01-08,"b'RT @AnExpertOne1: $ZIOP \n\nStock Offering price a year ago, was right about here; below that?  Seeing many top holders add, not subtract, th\xe2\x80\xa6'"
2021-01-08,"b'$ZIOP \n\nStock Offering price a year ago, was right about here; below that?  Seeing many top holders add, not subtract, that believe in the Science (but not the previous Board) &amp; I bet few if any were waiting for only $3.20 to sell shares.\n\nHuge potential in 2021 if they deliver!'"
2021-01-08,"b""$ZIOP's Aroon indicator reaches into Uptrend on December 23, 2020. View odds for this and other indicators: https://t.co/vd7300uqiT #ZiopharmOncology #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/oWMo0Nerzd"""
2021-01-08,"b'$ZIOP \n\nWould be nice to see at least a move up to $3.50 here (of course should be much higher); for traders (&amp; price flipper/fighters) much room above to do that....RSI is only 61, right in that sweet spot.\n\nBig news next week?  Better Board, surprise data, or deal, or more?\n\n;)'"
2021-01-08,b'Reversed from Down today: $FITBP $KLAC $AMD $AMAT $NTES $INCY $PTON $DOCU $ADI $FNLC $GMBL $ZIOP $MDGL $OFIX $LFTRU $ALKS $FSLF $ACLS $SYNL $NOVT ... https://t.co/uuYYhupj1A'
2021-01-08,b'$ZIOP what a Company  5.67 % change recently https://t.co/orYbtqH9e1'
2021-01-08,b'$ZIOP  new alert at https://t.co/A7qrDarJHY  #stocks #daytrading  #NYSE #NASDAQ #market 162'
2021-01-08,"b'RT @AnExpertOne1: January 07, 2021\n\n4:30 pm ET\n\n*Discovery Capital Management Reports In 13G Filing A 5.13% Stake In Ziopharm Oncology\n\nBen\xe2\x80\xa6'"
2021-01-08,b'RT @frank_naccarato: Biggest Surprises but not necessarily largest gainers:\n$CAPR +9.64%        \n$CDEV +16.37%     +146.2 portfolio gain\n$F\xe2\x80\xa6'
2021-01-08,"b""Biggest Surprises but not necessarily largest gainers:\n$CAPR +9.64%        \n$CDEV +16.37%     +146.2 portfolio gain\n$FASGX +0.25% Asset Fund 16% portfolio gain\n$RIDE +7.92%          \n$TELL +6.11%\n$WKHS +16.70%   +821.6 portfolio gain\n$ZIOP +5.84%\nLet's see what tomorrow brings..."""
2021-01-08,b'RT @Biotech2050: #JPM21 #JPMorgan $BMY $TGTX $XLRN $KPTI $PGEN $ZIOP $ACAD $HALO $SGMO \n\nWhich other companies\xe2\x80\x99 presentations are you looki\xe2\x80\xa6'
2021-01-08,"b'RT @AnExpertOne1: $ZIOP\n\nWow, nearly all the way back down to $3 - but, typical of these nuts....give them an inch they take a Mile!\n\nJust\xe2\x80\xa6'"
2021-01-08,"b'RT @AnExpertOne1: January 07, 2021\n\n4:30 pm ET\n\n*Discovery Capital Management Reports In 13G Filing A 5.13% Stake In Ziopharm Oncology\n\nBen\xe2\x80\xa6'"
2021-01-07,"b'January 07, 2021\n\n4:30 pm ET\n\n*Discovery Capital Management Reports In 13G Filing A 5.13% Stake In Ziopharm Oncology\n\nBenzinga\n\n$ZIOP'"
2021-01-07,"b'$ZIOP New Form SC 13G for ZIOPHARM Oncology, Inc.\nFrom our Stock News Alerts App'"
2021-01-07,"b""$ZIOP Discovery Capital Management discloses 13% stake; run by a Tiger CUB, Robert Citrone, firm had a poor six-year run through 2019 per article; don't know what it did in 2020; but ZIOP needs all the institutional support it can get; been such a fiasco.\n\nhttps://t.co/KzXy44KQoe"""
2021-01-07,"b'$ZIOP Discovery Capital Management, LLC / CT has filed Form SC 13G with SEC. Reporting 5.13% Ownership.\n\nhttps://t.co/t5CkFUZh7T'"
2021-01-07,"b'$ZIOP [15s. delayed] filed form SC 13G on January 07, 16:21:32 https://t.co/rgoHBydnhG'"
2021-01-07,b'$ZIOP\n\nDecent size of 2400 Call options volume-  58% traded on the Ask'
2021-01-07,b'Was Cellectis biggest hit for a long time - 2 babies dosed by CU &amp; it launched the share price high - from one of these slides&gt;\n\nSuccessful Compassionate Use in Pediatric ALL\n\xc2\xa7  Two infants injected with UCART19 \xc2\xa7  Still in complete remission today\n\nhttps://t.co/BxiJ17UQlr\n\n$ZIOP'
2021-01-07,"b'$ZIOP \n\nJust an FYI - Compassionate Use cases can be quite relevant; we know of what Cellectis accomplished &amp; here is another one cited in 2018&gt;\n\n""We report on first cases of implementation of this approach in a setting of compassionate use program.""\n\nhttps://t.co/OQy4IyS6sO'"
2021-01-07,b'Another one - Cytokine focused - engineered IL2 agonist &amp; w/ CD19 CarT in combo - I betcha nowhere near what $ZIOP has (or PGEN) &amp; yet the wackjobs will value it twice the level of Ziopharm (100% sure!....lol).\n\nSynthekine  #10 on the list.....\n\nhttps://t.co/egqPEH3fIn'
2021-01-07,"b'$ZIOP\n\nLooks like Neogene to IPO this year - 10 to 1, it prices 2 to 3 times higher than (Phase 2) Ziopharm with nothing in the clinic!...lol.\n\n""The company is focused on developing neoantigen T-cell therapies.""\n\nAnd how about Werewolf Therapeutics? (LOL)\n\nhttps://t.co/egqPEH3fIn'"
2021-01-07,b'$ZIOP price movement 7.04 % https://t.co/NX7N2PHnnM'
2021-01-07,b'RT @Biotech2050: #JPM21 #JPMorgan $BMY $TGTX $XLRN $KPTI $PGEN $ZIOP $ACAD $HALO $SGMO \n\nWhich other companies\xe2\x80\x99 presentations are you looki\xe2\x80\xa6'
2021-01-07,"b'$ZIOP\n\nWow, nearly all the way back down to $3 - but, typical of these nuts....give them an inch they take a Mile!\n\nJust what happens when/if Dr. Cooper says next week - ""those Compassionate Use Patients dosed with RPM CD19 CarT have improved dramatically""....etc.\n\nOther news too'"
2021-01-07,"b""Rose Above Previous Day's High today: $SSSS $PQG $ELA $NMM $EVY $CCF $RILYZ $STRT $OCFC $FTSL $AIC $ABTX $STBA $LOVE $TOT $NSEC $ZIOP $INTG $CVE $ARB ... https://t.co/TBYRpvrFqi"""
2021-01-07,b'RT @Biotech2050: #JPM21 #JPMorgan $BMY $TGTX $XLRN $KPTI $PGEN $ZIOP $ACAD $HALO $SGMO \n\nWhich other companies\xe2\x80\x99 presentations are you looki\xe2\x80\xa6'
2021-01-07,b'#JPM21 #JPMorgan $BMY $TGTX $XLRN $KPTI $PGEN $ZIOP $ACAD $HALO $SGMO \n\nWhich other companies\xe2\x80\x99 presentations are you looking forward too? Will a buyout be announced just before the event? https://t.co/LFwa2F4hGF'
2021-01-07,b'$ISR 1.31? OMG! adding!! MASSIVE NEWS. FDA APPROVED! $10 break easy\n\n$IONS $GBT $XON $CRSP $EDIT $NTLA $PBYI $BMRN $TSRO $CELG $BLUE $ALKS $ALNY $GILD $BIIB $AMGN $SGMO $ONCE $ENDP $PRGO $LCI $COLL $ANIP $MYL $OSUR $PODD $BIO $EW $ABT $MDT $ZIOP $KOOL $SRNE $CLLS $JNJ $MARA $RIOT https://t.co/tX1thF4NYY'
2021-01-07,b'RT @gcassidy718: $ZIOP watching closely ... Over $3.20 this rips 2.46 % change recently https://t.co/NX7N2PHnnM'
2021-01-07,"b'RT @AnExpertOne1: $ZIOP\n\nUp and over $3 here - price is well over the 50 MA on the weekly chart (~ $2.90) so, could be much room to run.  N\xe2\x80\xa6'"
2021-01-07,"b'$ZIOP\n\nUp and over $3 here - price is well over the 50 MA on the weekly chart (~ $2.90) so, could be much room to run.  Next up (on wk chart) would be $4.05 - the 200 MA.\n\n{May depend on the BIO index or news or not}\n\nAdded a few min. ago.'"
2021-01-07,"b'$ISR HAS the PATENT, will be a big #cancer #biotech implanting ""seeds "" for pancreatic cancer. Will replace horrible chemo\n\n$AMRH $UAVS $TRXC $NGD $FOLD $BDR $TOPS $CUR $BYFC $STNE $SNBR $LJPC $GLUU $TWTR $XLNX $LABU $NDRA $CPG $ASGN $TRVG $KN $TAL $NVT $CVI $MLNX $IP $TKC $ZIOP https://t.co/pwMuBtFt5H'"
2021-01-07,b'$ZIOP watching closely ... Over $3.20 this rips 2.46 % change recently https://t.co/NX7N2PHnnM'
2021-01-07,b'$ISR beautiful video describing everything\nhttps://t.co/OH5JYKjQZj\n\n$IONS $GBT $XON $CRSP $EDIT $NTLA $PBYI $BMRN $TSRO $CELG $BLUE $ALKS $ALNY $GILD $BIIB $AMGN $SGMO $ONCE $ENDP $PRGO $LCI $COLL $ANIP $MYL $OSUR $PODD $BIO $EW $ABT $MDT $ZIOP $KOOL $SRNE $CLLS $JNJ $MARA $RIOT'
2021-01-07,b'$ZIOP is winning today. : ) 2.64 % change recently https://t.co/orYbtqH9e1'
2021-01-07,b'$ZIOP buyer at $3.21  2.82 % change recently https://t.co/orYbtqH9e1'
